These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evidence that intrathymic islet transplantation does not prevent diabetes or subsequent islet graft destruction in RT6-depleted, diabetes-resistant BioBreeding/Worcester rats. Battan R; Mordes JP; Abreau S; Greiner DL; Handler ES; Rossini AA Transplantation; 1994 Mar; 57(5):731-6. PubMed ID: 8140636 [TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
5. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient. Fiedor P; Jin MX; Hardy MA; Oluwole SF Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Gottlieb PA; Berrios JP; Mariani G; Handler ES; Greiner D; Mordes JP; Rossini AA Diabetes; 1990 May; 39(5):643-5. PubMed ID: 1970541 [TBL] [Abstract][Full Text] [Related]
7. Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. Uchikoshi F; Ito T; Kamiike W; Nakao H; Makino S; Miyasaka M; Nozawa M; Matsuda H Transplantation; 1996 Jun; 61(11):1629-36. PubMed ID: 8669109 [TBL] [Abstract][Full Text] [Related]
8. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: a role for RT6+NKR-P1+ T cells. Tori M; Ito T; Kitagawa-Sakakida S; Nozawa M; Matsuda H; Shirakura R Transplantation; 2000 Jul; 70(1):32-8. PubMed ID: 10919571 [TBL] [Abstract][Full Text] [Related]
9. Intrathymic islet transplantation in the spontaneously diabetic BB rat. Posselt AM; Naji A; Roark JH; Markmann JF; Barker CF Ann Surg; 1991 Oct; 214(4):363-71; discussion 371-3. PubMed ID: 1835345 [TBL] [Abstract][Full Text] [Related]
10. Syngeneic islet transplantation in prediabetic BB-DP rats--a synchronized model for studying beta-cell destruction during the development of IDDM. Christensen UB; Sparre T; Cooke A; Andersen HU; Mandrup-Poulsen T; Nerup J Autoimmunity; 1998; 28(2):91-107. PubMed ID: 9771979 [TBL] [Abstract][Full Text] [Related]
12. Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats. Markmann JF; Posselt AM; Bassiri H; Brayman KL; Woehrle M; Hickey WF; Silvers WK; Barker CF; Naji A Transplantation; 1991 Oct; 52(4):662-7. PubMed ID: 1926346 [TBL] [Abstract][Full Text] [Related]
13. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4. Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981 [TBL] [Abstract][Full Text] [Related]
14. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711 [TBL] [Abstract][Full Text] [Related]
15. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats. Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220 [TBL] [Abstract][Full Text] [Related]
16. Transplantation of purified islet cells in diabetic BB rats. Pipeleers D; Pipeleers-Marichal M; Markholst H; Hoorens A; Klöppel G Diabetologia; 1991 Jun; 34(6):390-6. PubMed ID: 1832111 [TBL] [Abstract][Full Text] [Related]
17. Cultured neonatal islet transplants in alloxan-treated and spontaneously diabetic rats. Hegre OD; Serie JR; Weinhaus AJ; Ketchum RJ; Enriquez AJ; Esteban MM Horm Metab Res Suppl; 1990; 25():108-16. PubMed ID: 2088948 [TBL] [Abstract][Full Text] [Related]
18. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice. Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822 [TBL] [Abstract][Full Text] [Related]
19. The TheraCyte™ device protects against islet allograft rejection in immunized hosts. Kumagai-Braesch M; Jacobson S; Mori H; Jia X; Takahashi T; Wernerson A; Flodström-Tullberg M; Tibell A Cell Transplant; 2013; 22(7):1137-46. PubMed ID: 23043940 [TBL] [Abstract][Full Text] [Related]
20. The role of MHC compatibility in recurrence of autoimmune type I diabetes mellitus: comparison of the immune response of BB/W rats to pancreatic islet and heart allografts. Tezuka K Bull Osaka Med Coll; 1990 Nov; 36(1-2):57-69. PubMed ID: 2135645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]